Table 3.

Prevalence of MSP1 antibodies seropositivity in children who never received SMC and children that SMC for 1, 2 and 3 years

	n	%	95% CI	Unadjusted			Adjusteda
				OR	95% CI	p	OR	95% CI	p
No SMC	145	91.7	87.4–96.1	Ref	–	–	Ref	–	–
SMC 1Y	225	83.0	78.5–87.5	0.43	0.24–0.84	0.013	0.47	0.24–0.92	0.028
SMC 2Y	195	84.1	79.3–88.8	0.47	0.24–0.92	0.028	0.52	0.26–1.03	0.068
SMC 3Y	202	87.4	83.1–91.8	0.62	0.31–1.24	0.18	0.71	0.35–1.43	0.34
SMC 1–3Y	622	84.7	0.82–0.87	0.49	0.27–0.90	0.023	0.55	0.29–1.01	0.05

SMC 1Y received SMC for 1 year, SMC 2Y received SMC for 2 years, SMC 3Y received SMC for 3 years, SMC 1–3Y received SMC for 1, 2, or 3 years

^aAdjusted for age, gender and malaria infection